“…Similar to the cell-scale models reviewed in Section 3 , these phenomena can be modeled by discrete [ 33 , 87 , 88 , 122 , 123 , 126 , 130 , 131 , 132 ], continuous [ 128 , 129 , 133 , 134 ], or hybrid [ 127 , 135 , 136 ] approaches. In discrete vascular models both the pre-existing and the angiogenic vasculature are frequently approximated by a 1D network of connected straight cylinders with the flow in each cylinder simulated using the 1D Poiseuille law [ 33 , 87 , 88 , 122 , 123 , 126 , 130 , 131 , 132 ]. In continuous vascular flow models the vasculature is described with a spatially averaged, continuous variable (e.g., vasculature density or vascular volume fraction), and the transport of the substance of interest (e.g., drug or nutrient) through the interstitial space is described with a reaction-diffusion-advection model [ 128 , 129 , 133 , 134 ] describing the delivery, diffusion, and the transport of that substance due to bulk fluid flow.…”